The National Institute for Health and Care Excellence (NICE) has published its first batch of Medtech Innovation Briefings on a range of novel technologies, including a device to cool the brain in heart attack patients and a hydrosurgery device for cleaning wounds.
The Briefings aim to provide support to commissioners and clinicians considering the use of the latest medical devices and technologies on the National Health Service, though they do not make recommendations on value nor whether they should be provided locally.
Nevertheless, through the provision of evidence-based information on each product and its potential place in the treatment pathway, it is hoped that the briefings will help encourage faster uptake of innovative treatment approaches by the NHS.
Those published this morning (Tuesday) are for: the Versajet II hydrosurgery system, which enables a surgeon to precisely select, excise and evacuate nonviable tissue, bacteria and contaminants from wounds, burns and soft tissue; PressureWire FFR measurement system, designed to allow physicians to quickly and easily navigate tortuous vessels, which may reduce procedure time and eliminates the need for additional delivery devices; Neutrophil gelatinase-associated lipocalin (NGAL) test for kidney injury; and the RhinoChill intranasal cooling system, a device which cools the brain by spraying a coolant-oxygen mixture into the nasal cavity.
